OpenFilings

Keros Therapeutics, Inc.

Form10-Q

Report Period2024-03-31

Date Filed2024-05-08

Time Filed08:03:42

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
EX-31.1
EX-31.2
EX-32.1
Filing on SEC Edgar